EATSET Biotechnology Seminar/Transfusion Workshop
-------------------------------------------------
and
Formal Launching of New Autotransfusion Device
15-16 August 2002
Abuja Sheraton Hotels & Towers
Nigeria
Dear colleagues,
kindly publish the above seminar coming soon in Nigeria in the field
of biomedical and blood transfusion. All are cordially invited to
this programme which promotes collaboration between the north-south
and south-south regions.
Grateful,
Dr.O O Ovadje
FMCA
mailto:oovadje@excite.com
--
INTRODUCTION
The Emergency Autologous Transfusion device was designed to assist
doctors from developing countries particularly Surgeons, Anaesthesi-
ologists, Gynaecologists and Obstetricians to promote safe blood
transfusion practices in the face of current threat by blood borne
diseases such as HIV/AIDS and Hepatitis.
The EATSET device is the result of the EATSET project sponsored by
the United Nations Development Program as part of UNDP�s support for
social and sustainable development in Nigeria. The project was exe-
cuted by the World Health Organisation (1994 1996) on the recommen-
dation of Prof. Watson Williams (WHO) consultant for blood safety.
The first workshop and seminar took place on May 29th 31st, 1995 at
the Sheraton Hotel, Lagos and was sponsored by the United Nations De-
velopment Program. The seminar was designed to educate the general
public about the advantages of Autotransfusion and to discuss the po-
tential for introducing a simple and affordable device, the EATSET
for medical practise in developing countries. The seminar was unani-
mous in its declaration of the need to refine the EATSET device and
to promote safe blood transfusion practices in Nigeria. The UNDP
through WHO�s execution sponsored the refinement of the device with
Engr. Claude Fell, President of BIOSAFE, Switzerland as International
Consultant and Professor Asalor of the department of Production Engi-
neering, University of Benin, and Dr. Nnadi, CEO of Scientific Equip-
ment Development Institute, Enugu as National Consultants. The device
was subjected to Alpha and Beta clinical trials between 1996 and 1999
in Switzerland and in Nigeria (See Prof. Dennis Morel�s letter at
http://www.eatset.com/speeches/genevauniv ).
It has been judged to be a very useful tool in the management of pa-
tients who hitherto die from internal bleeding such as ruptured Ec-
topic pregnancies, road traffic accidents and aneurysmal ruptures
(find WHO report of Geneva trials in 1996).
There is ample evidence that the equipment is a major contribution to
Global Blood Safety as it encourages the use of a patient�s own blood
when the need arises. This was recognised by the World Health Organi-
sation at the World Health Assembly in Geneva, Switzerland, May 18,
2000 during the Sasakawa Award.
The equipment has won numerous international and national awards. Dr.
Ovadje continues to use the financial rewards of such awards to pro-
mote the device. About 10,000 units of the device are being manufac-
tured abroad and the equipment is now ready to be introduced into
medical practice in Nigeria and other developing countries. A work-
shop and seminar to educate medical practitioners on its use and to
popularise one of the few successfully home grown technologies is
hereby proposed for the month of June, 2002.
The project has a good track record and participated as finalists at
the Developmental Marketplace of the World Bank in Washington, D.C.
on February 8 9, 2000. It won the World Bank Institute Certificate
Award 2002. The project has always fulfilled its counterpart funding
obligations through its research funds made possible by its numerous
international monetary awards. (the World Health Organisation - Sasa-
kawa award, Switzerland 2000, the World Intellectual Property Organi-
sation Gold award, 1995, the Best African Inventor award of the OAU,
Addis Ababa, Ethiopia, 1995 and recently the ARCO Excellence in Sci-
ence and Technology Gold award 2001 in London).
The introduction of the EATSET device into medical practice in Nige-
ria and the developing world will reduce the cost of procuring ho-
mologous blood and the risk of acquiring HIV/AIDS through blood
transfusion and a major contribution by Nigeria to WHO�s Global Blood
Safety Program. It is the vision of the EATSET program to broaden its
R&D activities through collaborative activities by creating the North
South and South linkages.
For further information contact:
Dr. O.O. Ovadje <oovadje@excite.com>
--
To send a message to AFRO-NETS, write to: afro-nets@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe afro-nets OR unsubscribe afro-nets
To contact a person, send a message to: afro-nets-help@usa.healthnet.org
Information and archives: http://www.afronets.org